CJC-1295/Ipamorelin Blend 5/5MG

Description

Introducing CJC-1295/Ipamorelin Blend 5mg/5mg from Peptide Therapeutics Institute, a synergistic peptide combination widely studied for its role in stimulating endogenous growth hormone (GH) release, supporting recovery pathways, and optimizing anabolic signaling. CJC-1295, a long-acting GHRH analog, and Ipamorelin, a selective ghrelin receptor agonist, are individually recognized for promoting pulsatile GH secretion with minimal influence on cortisol and prolactin in research models. When combined, they provide complementary mechanisms that may enhance both the amplitude and consistency of GH signaling, offering broad utility in studies involving tissue repair, metabolic function, body composition, and performance recovery. Research models suggest this blend may support IGF-1 modulation, protein synthesis pathways, and cellular regeneration, making it valuable for investigations into aging, musculoskeletal recovery, and systemic adaptation. Advance your research into endocrine optimization, recovery biology, and regenerative signaling with Peptide Therapeutics Institute’s CJC-1295/Ipamorelin Blend 5mg/5mg.

Features

• Dual-peptide formulation studied for enhanced growth hormone release
• Supports IGF-1 signaling, protein synthesis, and cellular recovery pathways
• Investigated for muscle tissue repair, fat metabolism, and performance recovery
• Selective GH stimulation with minimal impact on cortisol and prolactin in research models
• Synergistic activity promoting endocrine balance and systemic adaptation
• Ideal for aging, metabolic, and musculoskeletal recovery research models

Why Choose Peptide Therapeutics Institute’s CJC-1295/Ipamorelin Blend 5mg/5mg?

For researchers exploring growth hormone dynamics, recovery optimization, and metabolic regulation, Peptide Therapeutics Institute’s CJC-1295/Ipamorelin Blend 5mg/5mg delivers the complementary benefits of two extensively studied GH-modulating peptides. This unique pairing is formulated to support sustained and physiologically relevant GH signaling across diverse experimental settings and is frequently utilized in models of muscle recovery, fat oxidation, and age-related anabolic decline. With research-grade purity and reliable peptide consistency, this blend supports reproducible outcomes in preclinical investigations. Its water solubility and molecular compatibility make it adaptable to a wide range of laboratory protocols. Peptide Therapeutics Institute maintains rigorous quality standards to support advanced endocrine and regenerative research. Choose this blend to deepen your understanding of growth hormone–mediated repair and adaptation pathways.

Specs

Volume: 5mg CJC-1295 / 5mg Ipamorelin
Purity: Research Grade

Composition:

• CJC-1295 and Ipamorelin Peptide Blend

Molecular Weight: Varies by peptide chain

Stability: Stable under standard laboratory storage conditions